Clinical Trial Update: Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke [Phase 4]

View source ↗

Summary

A phase 4 trial comparing antiplatelet therapy versus r-tPA for acute mild ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Antiplatelet therapy (antiplatelet agents)
• recombinant tissue plasminogen activator (tissue plasminogen activator (rt-PA))

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Stroke | Phase 4 | Status: COMPLETED